Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--letter

Clin Cancer Res. 2013 Aug 1;19(15):4290. doi: 10.1158/1078-0432.CCR-13-1321. Epub 2013 Jun 13.

Authors

Lorenza Rimassa, Jordi Bruix, Massimo Broggini, Armando Santoro

PMID: 23766362
DOI: 10.1158/1078-0432.CCR-13-1321

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / pharmacology*
Humans
Proto-Oncogene Proteins c-met / metabolism*
Pyrrolidinones / pharmacology*
Quinolines / pharmacology*
Tubulin Modulators / pharmacology*

Substances

Antineoplastic Agents
Pyrrolidinones
Quinolines
Tubulin Modulators
Proto-Oncogene Proteins c-met